Investing

Exscientia Plc : EXAI

EXAI

Stock Data

$4.84

$0.00 (0.00%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Exscientia Plc is a pioneering pharmatech company based in Oxford, UK, leveraging artificial intelligence to revolutionize drug discovery and development. Founded in 2012, it specializes in using AI to identify new drug targets, design drug candidates, and optimize patient selection. Its innovative platform streamlines the creation of small molecule drugs, aiming to deliver effective therapies faster and more efficiently than traditional methods.

All EXAI Articles

1 Article

Trey Thoelcke | Mar 28, 2024 at 8:40 AM EDT

3 AI Stocks Wall Street Expects to Return Up to 595% in 2024

Is it too late to jump on the artificial intelligence bandwagon? Analysts anticipate huge upside in these three AI stocks.